BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 31, 2002
View Archived Issues
New modulators of nuclear hormone receptors covered by BMS patent
Read More
Aventis presents novel telomerase-inhibitory antitumor agents
Read More
Subtype-selective NMDA antagonists and their use in pain and other CNS disorders
Read More
CDK1 inhibitors in early development at Aventis
Read More
Abbott reveals novel alphavbeta3 modulators in recent patent
Read More
Sankyo describes new antiangiogenic agents with utility in diabetic retinopathy
Read More
Merck researchers identify novel gamma-secretase inhibitors for use in AD
Read More
Promising safety results reported for CpG-7909 as adjuvant to antitumor vaccination
Read More
Safety and efficacy of oral ibandronate in breast cancer-related bone events
Read More
Potential use of MEN-10755 in recurrent non-small cell lung cancer
Read More
R-115777 in myelodysplastic syndrome
Read More
Improved safety profile reported for liposome-encapsulated mitoxantrone in advanced cancer
Read More
New data on the tolerability of BBR-3438 in advanced solid tumors
Read More
Comparison of lumiracoxib and celecoxib in osteoarthritis of the knee
Read More
Preliminary phase III results for LAX-101 in Huntington's disease
Read More
ETI-104 reported to be safe and effective in systemic lupus erythematosus
Read More
G17DT increases median survival time of patients with advanced pancreatic cancer
Read More
Effects of MRA on serum VEGF levels in RA patients
Read More
Advexin studied in combination with docetaxel and doxorubicin for advanced breast cancer
Read More
Second phase III trial fails to demonstrate MorphiDex's superiority to morphine
Read More
Lead tetracycline antibiotic candidate selected at Paratek
Read More
Lilly launches Xigris in E.U. for severe sepsis
Read More
Inspire plans to file INS-365 Ophthalmic NDA based on existing data
Read More
FDA issues approvable letter for Hectorol Capsules sNDA
Read More
New class of CpG oligonucleotides with promise for HCV infection
Read More
NDA submitted for once-daily Cipro XR in complicated UTIs
Read More
Approvable letter for Olux expanded label
Read More